A new AI liver cancer system helped identify 51 liver lesions that had previously been overlooked on CT scans, including 15 that turned out to be malignant, according to a large clinical study.
Called the Liver Diagnosis Network, or LiON, the system analyses contrast-enhanced CT scans and incorporates clinical information to assess whether a liver lesion may be malignant. Researchers tested it across multiple centers before putting it into routine clinical practice in a single-arm trial involving more than 10,000 patients.
